Harmonizing COVID Vaccine Schedule Good Idea, But US FDA Should Remain Flexible, Advisors Say

Vaccines and Related Biological Products Advisory Committee also said that more data is needed to determine the groups that potentially could receive more than one periodic vaccine booster.

VRBPAC voting screenshot
An FDA official reads the vote total after the VRBPAC recommended harmonizing the COVID-19 vaccine composition. • Source: Screenshot of video

The US Food and Drug Administration plan for regular updates of the COVID-19 vaccines is a good idea, but advisory committee members suggested it also should be flexible.

The agency’s Vaccines and Related Biological Products Advisory Committee voted unanimously, 21-0, on 26 January that the vaccine composition should...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet